These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 20414935)

  • 1. p53 gene mutations and codon 72 polymorphism in ovarian carcinoma patients from Serbia.
    Malisic E; Jankovic R; Slavkovic D; Milovic-Kovacevic M; Radulovic S
    J BUON; 2010; 15(1):101-6. PubMed ID: 20414935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 gene alterations and human papillomavirus type 16 infection in early stages of cervical carcinoma in Serbia.
    Malisic E; Jankovic R; Majkic M; Dobricic J; Radulovic S
    J BUON; 2008; 13(4):525-32. PubMed ID: 19145674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients.
    Høgdall EV; Høgdall CK; Christensen L; Glud E; Blaakaer J; Bock JE; Vuust J; Nørgaard-Pedersen B; Kjaer SK
    Anticancer Res; 2002; 22(3):1859-64. PubMed ID: 12168882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.
    Xu Y; Yao L; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Xie Y
    Clin Cancer Res; 2005 Oct; 11(20):7328-33. PubMed ID: 16243804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P53 gene status in patients with advanced serous epithelial ovarian cancer in relation to response to paclitaxel- plus platinum-based chemotherapy and long-term clinical outcome.
    Gadducci A; Di Cristofano C; Zavaglia M; Giusti L; Menicagli M; Cosio S; Naccarato AG; Genazzani AR; Bevilacqua G; Cavazzana AO
    Anticancer Res; 2006; 26(1B):687-93. PubMed ID: 16739339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
    Hu Y; McDermott MP; Ahrendt SA
    Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility.
    To-Figueras J; Gene M; Gomez-Catalan J; Galan C; Firvida J; Fuentes M; Rodamilans M; Huguet E; Estape J; Corbella J
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):337-42. PubMed ID: 9162298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
    Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ
    Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline polymorphism of p53 codon 72 in gynecological cancer.
    Ueda M; Terai Y; Kanda K; Kanemura M; Takehara M; Yamaguchi H; Nishiyama K; Yasuda M; Ueki M
    Gynecol Oncol; 2006 Jan; 100(1):173-8. PubMed ID: 16168468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p53 codon 72 polymorphism and lung cancer risk.
    Fan R; Wu MT; Miller D; Wain JC; Kelsey KT; Wiencke JK; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1037-42. PubMed ID: 11045785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygous proline at codon 72 of p53 as a potential risk factor favoring the development of undifferentiated thyroid carcinoma.
    Boltze C; Roessner A; Landt O; Szibor R; Peters B; Schneider-Stock R
    Int J Oncol; 2002 Nov; 21(5):1151-4. PubMed ID: 12370767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of p53 codon 72 polymorphism and codon 249 mutations in Southern India in relation to age, alcohol drinking and smoking habits.
    Pandima Devi K; Sivamaruthi B; Kiruthiga PV; Karutha Pandian S
    Hum Exp Toxicol; 2010 Jun; 29(6):451-8. PubMed ID: 19948747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of TP53 codon 72 polymorphism with susceptibility to ovarian carcinomas in Serbian women.
    Malisic EJ; Jankovic RN; Jakovljevic KV; Radulovic SS
    Eur J Obstet Gynecol Reprod Biol; 2013 Jan; 166(1):90-3. PubMed ID: 23092908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis.
    Wang YC; Chen CY; Chen SK; Chang YY; Lin P
    Clin Cancer Res; 1999 Jan; 5(1):129-34. PubMed ID: 9918210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia.
    Hadhri-Guiga B; Toumi N; Khabir A; Sellami-Boudawara T; Ghorbel A; Daoud J; Frikha M; Gargouri A; Mokdad-Gargouri R
    Cancer Genet Cytogenet; 2007 Oct; 178(2):89-93. PubMed ID: 17954263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential increase in the prognostic value of p53 mutation by Pro72 allele in stage I non-small-cell lung cancer.
    Chien WP; Wong RH; Wu TC; Cheng YW; Chen CY; Lee H
    Ann Surg Oncol; 2009 Jul; 16(7):1918-24. PubMed ID: 19434453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distant metastases in ovarian cancer: association with p53 mutations.
    Sood AK; Sorosky JI; Dolan M; Anderson B; Buller RE
    Clin Cancer Res; 1999 Sep; 5(9):2485-90. PubMed ID: 10499623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer.
    Lee JM; Shun CT; Wu MT; Chen YY; Yang SY; Hung HI; Chen JS; Hsu HH; Huang PM; Kuo SW; Lee YC
    Mutat Res; 2006 Feb; 594(1-2):181-8. PubMed ID: 16318864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 codon 72 polymorphism and the risk of lung cancer in a Korean population.
    Piao JM; Kim HN; Song HR; Kweon SS; Choi JS; Yun WJ; Kim YC; Oh IJ; Kim KS; Shin MH
    Lung Cancer; 2011 Sep; 73(3):264-7. PubMed ID: 21316118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 mutations in epithelial ovarian cancers: possible role in predicting chemoresistance.
    Laframboise S; Chapman W; McLaughlin J; Andrulis IL
    Cancer J; 2000; 6(5):302-8. PubMed ID: 11079169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.